Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedJun 07, 2023
DataAggregated Company Financials
Companies6
  • 7D-1.8%
  • 3M-5.7%
  • 1Y17.8%
  • YTD-5.6%

Over the last 7 days, the Pharma industry has dropped 1.8%, driven by Duopharma Biotech Berhad declining 2.9%. This takes the industry's 12 month performance to a gain of 18%. In the next few years earnings are forecast to be pretty stable.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 07 Jun 2023RM4.5bRM2.6bRM304.7m14.7x14.9x1.8x
Fri, 05 May 2023RM4.6bRM2.5bRM289.8m13.6x16x1.9x
Sun, 02 Apr 2023RM4.8bRM2.5bRM289.8m13.1x16.5x1.9x
Tue, 28 Feb 2023RM4.9bRM2.5bRM288.7m13.2x17x2x
Thu, 26 Jan 2023RM4.7bRM2.4bRM270.7m13x17.2x1.9x
Sat, 24 Dec 2022RM4.7bRM2.4bRM270.7m13.4x17.5x1.9x
Mon, 21 Nov 2022RM4.2bRM2.4bRM261.3m12.5x16.2x1.7x
Wed, 19 Oct 2022RM4.0bRM2.4bRM249.0m11.6x15.9x1.7x
Fri, 16 Sep 2022RM4.0bRM2.4bRM249.0m11.8x16.1x1.7x
Sun, 14 Aug 2022RM3.9bRM2.3bRM226.0m14.2x17x1.7x
Tue, 12 Jul 2022RM3.5bRM2.3bRM226.0m13.8x15.6x1.5x
Thu, 09 Jun 2022RM3.8bRM2.3bRM226.0m14.2x17x1.7x
Sat, 07 May 2022RM4.0bRM2.2bRM204.5m16.5x19.3x1.8x
Mon, 04 Apr 2022RM3.9bRM2.2bRM204.5m16.2x19.3x1.8x
Wed, 02 Mar 2022RM3.8bRM2.2bRM203.8m15.8x18.8x1.7x
Fri, 28 Jan 2022RM3.5bRM2.1bRM187.4m15.5x18.9x1.7x
Sun, 26 Dec 2021RM3.7bRM2.1bRM187.4m15.4x19.6x1.7x
Tue, 23 Nov 2021RM3.7bRM2.1bRM170.6m20.5x22x1.8x
Thu, 21 Oct 2021RM3.9bRM2.0bRM166.6m21x23.5x1.9x
Sat, 18 Sep 2021RM4.0bRM2.0bRM166.5m20.5x24.2x2x
Mon, 16 Aug 2021RM3.9bRM2.0bRM166.5m19.3x23.3x1.9x
Mon, 31 May 2021RM4.6bRM2.0bRM167.4m17.8x27.4x2.3x
Thu, 04 Mar 2021RM4.6bRM1.9bRM169.0m19.2x27.4x2.4x
Sun, 06 Dec 2020RM5.6bRM2.0bRM169.6m17.7x33.1x2.9x
Wed, 09 Sep 2020RM5.3bRM2.0bRM180.8m16.9x29.3x2.7x
Price to Earnings Ratio

18.5x


Total Market Cap: RM3.4bTotal Earnings: RM180.8mTotal Revenue: RM2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 21.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Malaysian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.9x which is lower than its 3-year average PE of 21.8x.
  • The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 9.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market-1.02%
Healthcare1.17%
Pharma-1.76%
Pharma-1.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RHONEMA Rhone Ma Holdings BerhadRM0.764.1%
+RM6.6m
4.9%PE13.5x
YSPSAH Y.S.P. Southeast Asia Holding BerhadRM2.551.2%
+RM4.2m
28.8%PE9.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

YSPSAH

RM2.55

Y.S.P. Southeast Asia Holding Berhad

7D

1.2%

1Y

28.8%

DPHARMA

RM1.36

Duopharma Biotech Berhad

7D

-2.9%

1Y

-2.2%

KOTRA

RM5.31

Kotra Industries Berhad

7D

-3.6%

1Y

24.9%

AHEALTH

RM3.89

Apex Healthcare Berhad

7D

-1.3%

1Y

34.1%

RHONEMA

RM0.76

Rhone Ma Holdings Berhad

7D

4.1%

1Y

4.9%